The Medicines Co. (MDCO) said its third-quarter net loss narrowed to $3.20 million or $0.06 per share from $13.22 million or $0.25 per share in the prior year quarter. Non-GAAP net income for the quarter was $5.07 million or $0.10 per share.
Net revenue for the third quarter grew to $98.79 million from $88.13 million in the comparable period. On average, 5 analysts polled by Thomson Reuters expected loss per share of $0.05 on revenues of $96.99 million for the quarter. Analysts' estimate typically excludes one-time items.
For the full year 2009, the company now expects loss per share in the range of $0.25 - $0.19 compared with its prior range of profit of $0.24 - $ 0.34. Also, the company lowered its full-year non-GAAP earnings per share view to $0.14 - $ 0.24 from its earlier range of $0.88-$ 1.10. Six analysts expect earnings per share of $0.06 for the year 2009.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.